PAR Capital Management’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-481,400
| Closed | -$168K | – | 88 |
|
|
2018
Q2 | $168K | Sell |
481,400
-3,949,901
| -89% | -$1.38M | ﹤0.01% | 82 |
|
|
2018
Q1 | $6.65M | Sell |
4,431,301
-1,511,008
| -25% | -$2.27M | 0.07% | 71 |
|
|
2017
Q4 | $8.44M | Sell |
5,942,309
-457,691
| -7% | -$650K | 0.09% | 66 |
|
|
2017
Q3 | $14.7M | Hold |
6,400,000
| – | – | 0.17% | 55 |
|
|
2017
Q2 | $8.64M | Hold |
6,400,000
| – | – | 0.1% | 63 |
|
|
2017
Q1 | $13.7M | Hold |
6,400,000
| – | – | 0.17% | 54 |
|
|
2016
Q4 | $28.2M | Hold |
6,400,000
| – | – | 0.37% | 47 |
|
|
2016
Q3 | $31M | Hold |
6,400,000
| – | – | 0.45% | 44 |
|
|
2016
Q2 | $21.1M | Buy |
6,400,000
+1,035,000
| +19% | +$3.42M | 0.35% | 44 |
|
|
2016
Q1 | $19M | Buy |
+5,365,000
| New | +$19M | 0.31% | 50 |
|